ArticlePloS one2025
Molecular and evolutionary determinants for protein interaction within a class II aldolase/Adducin domain.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The appearance of modular protein interaction domains represents a crucial step in the evolution of multicellularity. For example, the class II aldolase domain (ALDODOM) found within the Adducin gene family shares sequence and structural homology to a glycolytic aldolase enzyme found in many evolutionarily ancient phyla. ALDODOM is best known for direct binding to actin filaments through a tetrameric assembly lacking catalytic activity. Molecular details for additional ALDODOM interactions have not been resolved, nor have the sequence changes underlying the dramatic functional switch in the aldolase protein fold. Here we explore the molecular basis for the interaction between ALDODOM of Hts (Drosophila Adducin) and the mitotic spindle regulator, Mud. Our results suggest a distinct mode of interaction, as conserved actin-contacting residues on the tetramer surface were found dispensable for Mud binding. Instead, we identify a critical role for the ALDODOM C-terminal helix (CThelix), along with residues from the adjacent protomer that occur at a tetrameric interface conserved among domains and a subgroup of aldolase enzymes (ALDOENZs). Truncation of the CThelix from bacterial ALDOENZ, or chimeric fusion with that from Hts, confers ALDODOM-like Mud binding. Sequence database analyses suggest ALDODOM function may have arisen in the primitive metazoan phylum, Placozoa, which contains both an aldolase enzyme and domain capable of Mud binding. Finally, we identify a single, conserved arginine-to-glycine change that also permits Mud binding within the bacterial ALDOENZ. Our work provides molecular and evolutionary insights into the function of a conserved protein-binding domain within multicellular organisms.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.